MAPT and Alzheimer disease: To determine the mode of mixing of 4R and 3R tau in AD tau aggregates, we seeded 15N or 13C-labeled recombinant tau monomers with 10% AD brain-derived sarkosyl-insoluble tau (AD tau) (Fig. 1a) and characterized the resulting fibrils using solid-state NMR.